• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET CT作为肝细胞癌的一个预后因素

18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.

作者信息

Cho Eunae, Jun Chung Hwan, Kim Ban Seok, Son Dong Jun, Choi Won Suk, Choi Sung Kyu

机构信息

Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

出版信息

Turk J Gastroenterol. 2015 Jul;26(4):344-50. doi: 10.5152/tjg.2015.0152. Epub 2015 Jun 2.

DOI:10.5152/tjg.2015.0152
PMID:26039005
Abstract

BACKGROUND/AIMS: To elucidate the role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) imaging as an independent prognostic factor in hepatocellular carcinoma (HCC).

MATERIALS AND METHODS

A total of 104 patients with newly diagnosed HCC who underwent 18F-FDG-PET/CT imaging from 2009 to 2014 were reviewed retrospectively. The ratio of the maximal tumor standardized uptake value (SUV) to the mean mediastinum SUV (TSUVmax/MSUVmean) was evaluated as the predictive factor.

RESULTS

A high TSUVmax/MSUVmean ratio (≥3.1) was significantly associated with tumor burden indices, including α-fetoprotein (p<0.001), amino transaminase (AST) (p=0.007), tumor size (p=0.043), Tumor, Node, and Metastasis (TNM) stage (p<0.001), and Barcelona Clinic Liver Cancer (BCLC) staging (p<0.001). The mortality rate was higher (48.1% vs. 23.1%, p<0.001) in patients with a high TSUVmax/MSUVmean ratio (≥3.1). Among the 47 patients who underwent transarterial chemoembolization (TACE), patients with a high TSUVmax/MSUVmean ratio (≥3.1) were more likely to have recurrence following TACE (18/19 vs. 18/28, p=0.016).

CONCLUSION

A high TSUVmax/MSUVmean ratio on 18F-FDG-PET/CT imaging can serve as an independent prognostic factor in HCC and may predict tumor recurrence after TACE.

摘要

背景/目的:阐明18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F-FDG-PET/CT)成像作为肝细胞癌(HCC)独立预后因素的作用。

材料与方法

回顾性分析2009年至2014年期间104例新诊断的HCC患者,这些患者均接受了18F-FDG-PET/CT成像检查。将最大肿瘤标准化摄取值(SUV)与平均纵隔SUV的比值(TSUVmax/MSUVmean)作为预测因子进行评估。

结果

高TSUVmax/MSUVmean比值(≥3.1)与肿瘤负荷指标显著相关,包括甲胎蛋白(p<0.001)、氨基转移酶(AST)(p=0.007)、肿瘤大小(p=0.043)、肿瘤、淋巴结转移(TNM)分期(p<0.001)以及巴塞罗那临床肝癌(BCLC)分期(p<0.001)。高TSUVmax/MSUVmean比值(≥3.1)的患者死亡率更高(48.1%对23.1%,p<0.001)。在47例行经动脉化疗栓塞术(TACE)的患者中,高TSUVmax/MSUVmean比值(≥3.1)的患者TACE术后更易复发(18/19对18/28,p=0.016)。

结论

18F-FDG-PET/CT成像上的高TSUVmax/MSUVmean比值可作为HCC的独立预后因素,并可能预测TACE术后肿瘤复发。

相似文献

1
18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.18F-FDG PET CT作为肝细胞癌的一个预后因素
Turk J Gastroenterol. 2015 Jul;26(4):344-50. doi: 10.5152/tjg.2015.0152. Epub 2015 Jun 2.
2
The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.代谢肿瘤体积在无肝外转移的肝细胞癌患者中对氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)引导下经动脉化疗栓塞术和经动脉化疗灌注术的预测价值。
Ann Nucl Med. 2015 Jun;29(5):400-8. doi: 10.1007/s12149-015-0956-8. Epub 2015 Feb 5.
3
Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.18F-FDG PET/CT 检测在经 TACE 治疗后肝癌患者肿瘤活性和预测预后中的价值。
Clin Radiol. 2015 Feb;70(2):128-37. doi: 10.1016/j.crad.2014.09.020. Epub 2014 Nov 4.
4
Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.使用(18)F-FDG PET预测经动脉化疗栓塞治疗的中期肝细胞癌患者的肿瘤进展和生存情况。
Korean J Intern Med. 2015 May;30(3):308-15. doi: 10.3904/kjim.2015.30.3.308. Epub 2015 Apr 29.
5
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.18F-FDG PET/CT 对肝癌患者肝移植前血管侵犯的预测价值。
Clin Nucl Med. 2017 Apr;42(4):e183-e187. doi: 10.1097/RLU.0000000000001545.
6
Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.¹⁸F-氟代脱氧葡萄糖 PET/CT 对肝癌经动脉化学栓塞治疗的预测价值。
World J Gastroenterol. 2012 Jul 7;18(25):3215-22. doi: 10.3748/wjg.v18.i25.3215.
7
11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.11C-乙酸盐和18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描双模态成像用于预测经动脉化疗栓塞后的反应和预后
Medicine (Baltimore). 2018 Sep;97(37):e12311. doi: 10.1097/MD.0000000000012311.
8
Value of 18-FDG-positron emission tomography/computed tomography before and after transarterial chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: initial results.18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在接受肝移植的肝细胞癌患者经动脉化疗栓塞前后的价值:初步结果
Transplant Proc. 2011 Jul-Aug;43(6):2213-5. doi: 10.1016/j.transproceed.2011.05.023.
9
The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).18F-FDG PET/CT对经动脉化疗栓塞术(TACE)治疗的肝细胞癌的预后价值。
Theranostics. 2014 May 1;4(7):736-44. doi: 10.7150/thno.8725. eCollection 2014.
10
F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study.F-FDG PET/CT可预测晚期肝细胞癌患者的生存:一项多中心回顾性队列研究。
J Nucl Med. 2017 May;58(5):730-736. doi: 10.2967/jnumed.116.182022. Epub 2016 Oct 27.

引用本文的文献

1
PET/MRI: pictorial review of hepatobiliary and pancreatic applications.PET/MRI:肝胆胰应用的影像学综述
Abdom Radiol (NY). 2025 Feb;50(2):875-901. doi: 10.1007/s00261-024-04548-6. Epub 2024 Sep 10.
2
Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023.肝细胞癌中的代谢重编程:一项2011年至2023年的文献计量学与可视化研究
Front Pharmacol. 2024 Jul 16;15:1392241. doi: 10.3389/fphar.2024.1392241. eCollection 2024.
3
Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.
印度国家肝脏研究协会和印度放射与影像协会关于肝细胞癌诊断与成像的联合共识声明,纳入肝脏影像报告和数据系统
J Clin Exp Hepatol. 2019 Sep-Oct;9(5):625-651. doi: 10.1016/j.jceh.2019.07.005. Epub 2019 Aug 6.
4
Change in standardized uptake values in delayed 18F-FDG positron emission tomography images in hepatocellular carcinoma.肝细胞癌延迟18F-FDG正电子发射断层扫描图像中标准化摄取值的变化
Medicine (Baltimore). 2018 Oct;97(42):e12817. doi: 10.1097/MD.0000000000012817.
5
Signature of survival: a F-FDG PET based whole-liver radiomic analysis predicts survival after Y-TARE for hepatocellular carcinoma.生存特征:基于F-FDG PET的全肝放射组学分析预测肝细胞癌钇-90微球选择性体内放射治疗后的生存情况
Oncotarget. 2017 Dec 19;9(4):4549-4558. doi: 10.18632/oncotarget.23423. eCollection 2018 Jan 12.
6
Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection.18F-氟脱氧葡萄糖正电子发射断层扫描在接受手术切除的肝细胞癌患者中的临床应用价值
Ann Hepatobiliary Pancreat Surg. 2017 Nov;21(4):194-198. doi: 10.14701/ahbps.2017.21.4.194. Epub 2017 Nov 30.
7
F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma.用氟代脱氧葡萄糖正电子发射断层扫描评估肝细胞癌肝移植患者的生物学活性和预后
J Clin Transl Hepatol. 2017 Sep 28;5(3):224-234. doi: 10.14218/JCTH.2017.00014. Epub 2017 Jul 8.
8
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.治疗前F-18-FDG PET-CT对接受放射性栓塞治疗的肝细胞癌患者的预后价值。
World J Gastroenterol. 2016 Dec 21;22(47):10406-10414. doi: 10.3748/wjg.v22.i47.10406.